Buprenorphine 00054-0177
Product NDC
00054-0177- Manufacturer
- Hikma Pharmaceuticals Usa Inc.
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- October 8, 2009
- Listing Expires
- December 31, 2027
- Application
- ANDA078633
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 8 mg/1 |
Drug Class
Partial Opioid Agonist [EPC]Partial Opioid Agonists [MoA]
Packaging Options(1)
30 TABLET in 1 BOTTLE (0054-0177-13)